Habitual coffee intake and risk for nonalcoholic fatty liver disease: a two-sample Mendelian randomization study
- 27 August 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Nutrition
- Vol. 60 (4) , 1761-1767
Abstract
Purpose Epidemiological studies support a protective role of habitual coffee and caffeine consumption against the risk of non-alcoholic fatty liver disease (NAFLD). We aimed to investigate the causal relationship between coffee intake and the risk of NAFLD. Methods We performed a two-sample Mendelian randomization (MR) analysis using SNPs associated with habitual coffee intake in a published genome-wide association study (GWAS) as genetic instruments and summary-level data from a published GWAS of NAFLD (1122 cases and 399,900 healthy controls) in the UK Biobank. The causal relationship was estimated with the inverse weighted method using a 4-SNP and 6-SNP instrument based on the single largest non-UK Biobank GWAS (n = 91,462) and meta-analysis (n = 121,524) of GWAS data on habitual coffee intake, respectively. To maximize power, we also used up to 77 SNPs associated with coffee intake at a liberal significance level (p ≤ 1e-4) as instruments. Results We observed a non-significant trend towards a causal protective effect of coffee intake on NAFLD based upon either the 4-SNP (OR: 0.76; 95% CI 0.51, 1.14, p = 0.19) or 6-SNP genetic instruments (OR: 0.77; 95% CI 0.48, 1.25, p = 0.29). The result also remains non-significant when using the more liberal 77-SNP instrument. Conclusion Our findings do not support a causal relationship between coffee intake and NAFLD risk. However, despite the largest-to-date sample size, the power of this study may be limited by the non-specificity and moderate effect size of the genetic alleles on coffee intake.Keywords
Funding Information
- NIH/NIDDK grant (R01DK106540)
- The start-up fund of the Office of Vice President for Research of Wayne State University
This publication has 48 references indexed in Scilit:
- A systematic review and a dose–response meta-analysis of coffee dose and nonalcoholic fatty liver diseaseClinical Nutrition, 2019
- Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver DiseaseMedicina, 2019
- Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut–liver axisJournal of Nutritional Science, 2019
- Impact of Nutritional Changes on Nonalcoholic Fatty Liver DiseaseNutrients, 2019
- Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysisNutrition Reviews, 2018
- A Combination of Coffee Compounds Shows Insulin-Sensitizing and Hepatoprotective Effects in a Rat Model of Diet-Induced Metabolic SyndromeNutrients, 2017
- Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver DiseaseNutrients, 2017
- Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology, 2017
- Impact of coffee on liver diseases: a systematic reviewLiver International, 2013
- Beverage Consumption in the US PopulationJournal of the American Dietetic Association, 2006